KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
NEW YORK and LAVAL, Quebec, Feb. 08, 2016 -- Colgate-Palmolive Company ("Colgate") and Klox Technologies Inc. ("KLOX") have entered into agreements to globally commercialize and further develop KLOX’s human Oral Health technology platform. The agreements include a worldwide license to commercialize KLOX’s proprietary Biophotonic technology in the field of human Oral Health and an equity investment in KLOX by Colgate.
Dr. Lise Hébert, President and CEO of KLOX, stated: "We are extremely pleased to have Colgate-Palmolive, the leader in Oral Care, with activities in over 200 countries and territories be our global partner for our Oral Health platform. These agreements once again recognize the breadth of our technology platform. Furthermore, these agreements validate the value creation strategy we have adopted by partnering large potential indications with first in class partners, while building a specialized salesforce for products within Wound Care."
Suzan Harrison, President of Global Oral Care of Colgate, stated: "We are very pleased to have KLOX as a partner in the development of this exciting and new technology platform for the benefit of Oral Health."
|
|||
About Colgate-Palmolive Company:
Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet and Hill's Ideal Balance. For more information about Colgate's global business, visit the Company's web site at http://www.colgatepalmolive.com. To learn more about Colgate Bright Smiles, Bright Futures® oral health education program, please visit http://www.colgatebsbf.com.
About Klox Technologies Inc.:
KLOX is a specialty pharmaceutical company focused on developing and commercializing products based on its proprietary Biophotonic technology platform to address skin and soft tissue disorders. The company has a multi-franchise platform focusing on indications across Dermatology, Wound Care, and Oral Health.
To learn more about KLOX, please visit http://www.kloxtechnologies.com.
Colgate-Palmolive Company Media Contact: Mitali Chopra – [email protected] Klox Technologies Inc. Media Contact: Mr. Michael Rice – [email protected]
